LFG
ALT icon

Larson Financial Group’s Altimmune ALT Stock Holding History

Larson Financial Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$15 – 3775
2026
Q1 		$15 Sell
5
-5,301
-100% -$22.5K ﹤0.01% 3595
2025
Q4 		$19.2K Buy
5,306
+1
+0% +$4 ﹤0.01% 1751
2025
Q3 		$20K Buy
5,305
+5
+0.1% +$19 ﹤0.01% 1648
2025
Q2 		$20.5K Buy
5,300
+300
+6% +$1.62K ﹤0.01% 1479
2025
Q1 		$25K Hold
5,000
– – ﹤0.01% 1281
2024
Q4 		$36K Hold
5,000
– – ﹤0.01% 1005
2024
Q3 		$30.7K Buy
+5,000
New +$33.9K ﹤0.01% 1059

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Larson Financial Group's ALT Position: Q2 2026 in Review

Larson Financial Group sold out of Altimmune (ALT) in Q2 2026, closing a stake of 5 shares — an estimated $15 sold.

Larson Financial Group first reported a position in ALT in Q3 2024 and held it in 7 quarters. The position peaked at $36K in Q4 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Larson Financial Group reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
  • Larson Financial Group sold 5 Altimmune shares in Q2 2026, an estimated $15.
  • Larson Financial Group first reported a position in Altimmune in Q3 2024 and held it in 7 quarters.
  • Larson Financial Group's Altimmune position peaked at $36K in Q4 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.